Sort   by:  
 Page size 
UnknownDeterminants of pain severity changes in ambulatory patients with cancer: an analysis from Eastern Cooperative Oncology Group trial E2Z02.
Not available
S-EPMC3897256 | biostudies-literature
UnknownPhase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma.
Not available
S-EPMC5406425 | biostudies-literature
UnknownClarifying Prehistoric Parasitism from a Complementary Morphological and Molecular Approach.
Not available
S-EPMC3640563 | biostudies-literature
UnknownTrajectory, interactions, and predictors of higher symptom burden during induction therapy for multiple myeloma.
Not available
S-EPMC11618278 | biostudies-literature
UnknownSymptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors.
Not available
S-EPMC3143572 | biostudies-literature
UnknownRacial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis.
Not available
S-EPMC4368488 | biostudies-literature
UnknownPrechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer.
Not available
S-EPMC4794365 | biostudies-literature
UnknownMeasuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
Not available
S-EPMC3228083 | biostudies-literature
UnknownPatient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.
Not available
S-EPMC5953814 | biostudies-literature
UnknownEvaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
Not available
S-EPMC6579804 | biostudies-literature
Sort   by:  
 Page size